The startup provides nanoparticle analytical testing services specifically for the pharmaceutical and biotechnology sectors, utilizing single-particle size and chemical compositional analysis techniques. This enables clients to obtain precise characterization of nanoparticles used in diagnostics and therapeutics, ensuring compliance with regulatory standards and enhancing product development.
Funding
$4.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
The development and quality control of nanoformulations for therapeutics and diagnostics require detailed characterization of individual nanoparticles, but existing analytical tools lack the sensitivity and throughput needed to fully understand these complex systems. Traditional methods often require extensive sample preparation and modification, potentially altering the nanoparticles and hindering accurate analysis.
Solution
SPARTA Biodiscovery offers a benchtop instrument and analytical services based on Single Particle Automated Raman Trapping Analysis (SPARTA®) technology, enabling automated, label-free, high-throughput chemical characterization of individual nanoparticles. The SPARTA® system utilizes Raman spectroscopy and laser optical trapping to simultaneously analyze the size and chemical composition of nanoparticles without requiring modification. This technology allows for real-time dynamic reaction monitoring and is compatible with a wide range of nanoparticle types, including liposomes, viral vectors, exosomes, and polymersomes. SPARTA® provides comprehensive data for improved troubleshooting and process development of next-generation therapeutics, accelerating R&D and improving quality control in the life sciences sector.
Target Audience
The primary target audience includes pharmaceutical and biotechnology companies, academic institutions, and hospitals involved in the research, development, and manufacturing of nanomedicines and diagnostics.
Features
- Automated laser optical trapping combined with Raman spectroscopy for simultaneous size and chemical composition analysis on a single-particle basis
- Label-free and non-destructive analysis, eliminating the need for sample modification
- High-throughput analysis for efficient characterization of large nanoparticle populations
- Real-time dynamic reaction monitoring capabilities
- Dedicated software package (SPARTA® Control) for easy and efficient system interfacing and automated analysis
- Compatibility with a wide range of nanoparticle types, including exosomes, liposomes, viral vectors, and polymersomes
- Custom high-end light collection and detector assembly for sensitive detection
- Aqueous particle solutions can be directly interfaced with the system for rapid analysis without additional sample preparation